Adenocarcinoma News and Research

RSS
Adenocarcinoma is cancer that begins in cells that line certain internal organs and that have gland-like (secretory) properties.
Researchers develop software tool to noninvasively characterize pulmonary adenocarcinoma

Researchers develop software tool to noninvasively characterize pulmonary adenocarcinoma

Study evaluates efficacy of drug combinations in treating colorectal cancer

Study evaluates efficacy of drug combinations in treating colorectal cancer

Molecular diagnostic testing in lung cancer offers new hope for patients

Molecular diagnostic testing in lung cancer offers new hope for patients

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Researchers identify vulnerability of lung-cancer cells that can be exploited for new therapies

Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

Modifiable lifestyle factors may prevent progression of Barrett's-related esophageal cancer

Research may offer clues to why esophageal adenocarcinomas rates have increased rapidly

Research may offer clues to why esophageal adenocarcinomas rates have increased rapidly

Researchers identify patterns of mutations in early stage node negative lung adenocarcinoma

Researchers identify patterns of mutations in early stage node negative lung adenocarcinoma

Protein derived from Pacific cod may inhibit prostate cancer, researchers say

Protein derived from Pacific cod may inhibit prostate cancer, researchers say

MicroRNA expression signatures may help define progression of Barrett's esophagus

MicroRNA expression signatures may help define progression of Barrett's esophagus

Optimal lung cancer screening nodule size questioned

Optimal lung cancer screening nodule size questioned

Patient-specific cancer cell lines designed to predict chemotherapy sensitivity

Patient-specific cancer cell lines designed to predict chemotherapy sensitivity

Glimmer of hope for imatinib-resistant GIST

Glimmer of hope for imatinib-resistant GIST

RRM1 gene may better predict survival for pancreatic adenocarcinoma

RRM1 gene may better predict survival for pancreatic adenocarcinoma

VMAT use to deliver prostate intensity-modulated radiation therapy reduces treatment time

VMAT use to deliver prostate intensity-modulated radiation therapy reduces treatment time

Interim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA

Interim results from Seattle Genetics’ ASG-5ME phase I trial on metastatic PDA

Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

Gastrointestinal Cancers Symposium to be held from Jan. 24-26 in San Francisco, CA

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Quarter of incident lung cancer slow growing or indolent

Quarter of incident lung cancer slow growing or indolent

Boehringer Ingelheim receives FDA Priority Review for afatinib to treat EGFR mutation-positive NSCLC

Boehringer Ingelheim receives FDA Priority Review for afatinib to treat EGFR mutation-positive NSCLC

Beta blocker use linked to NSCLC patient survival

Beta blocker use linked to NSCLC patient survival

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.